FOLD - AMICUS THERAPEUTICS, INC.
14.33
-0.010 -0.070%
Share volume: 5,574,104
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$14.34
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-06-2024 | 02-19-2025 | 05-01-2025 | 07-31-2025 | 11-04-2025 | 02-20-2026 | |
| Assets | |||||||||
| Total Assets | 721.789 M | 749.484 M | 786.557 M | 785.033 M | 789.839 M | 815.303 M | 868.811 M | 949.870 M | |
| Current Assets | 431.239 M | 461.701 M | 498.474 M | 504.736 M | 510.799 M | 538.007 M | 594.066 M | 676.173 M | |
| Inventories | 60.759 M | 81.320 M | 115.338 M | 118.782 M | 132.412 M | 154.875 M | 177.928 M | 228.819 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 29.842 M | 50.727 M | 16.110 M | 36.194 M | 68.916 M | 72.296 M | 73.290 M | 79.526 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 209.761 M | 209.335 M | 233.647 M | 213.752 M | 181.657 M | 158.702 M | 190.553 M | 214.010 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 32.421 M | 31.161 M | 30.438 M | 29.383 M | 28.718 M | 28.570 M | 27.759 M | 27.108 M | |
| Other Assets | 258.129 M | 256.622 M | 257.645 M | 250.914 M | 250.322 M | 248.726 M | 246.986 M | 246.589 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 721.789 M | 749.484 M | 786.557 M | 785.033 M | 789.839 M | 815.303 M | 868.811 M | 949.870 M | |
| Total liabilities | 591.095 M | 616.961 M | 607.732 M | 590.988 M | 596.281 M | 610.999 M | 638.387 M | 675.629 M | |
| Total current liabilities | 142.102 M | 168.066 M | 158.138 M | 148.702 M | 152.890 M | 167.647 M | 198.930 M | 237.828 M | |
| Accounts Payable | 9.210 M | 32.057 M | 13.481 M | 12.947 M | 14.451 M | 13.893 M | 19.103 M | 28.630 M | |
| Other liabilities | 60.602 M | 59.956 M | 60.100 M | 52.175 M | 52.683 M | 52.030 M | 47.472 M | 45.141 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 388.391 M | 388.939 M | 389.494 M | 390.111 M | 390.708 M | 391.322 M | 391.985 M | 392.660 M | |
| Other liabilities | 60.602 M | 59.956 M | 60.100 M | 52.175 M | 52.683 M | 52.030 M | 47.472 M | 45.141 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 130.694 M | 132.523 M | 178.825 M | 194.045 M | 193.558 M | 204.304 M | 230.424 M | 274.241 M | |
| Common stock | 2.856 B | 2.872 B | 2.909 B | 2.929 B | 2.943 B | 2.960 B | 2.977 B | 3.017 B | |
| Retained earnings | -2.732 B | -2.748 B | -2.755 B | -2.740 B | -2.762 B | -2.786 B | -2.769 B | -2.767 B |